Background: Patients with chronic heart failure (chronic HF) are at high risk of cardiovascular death and recurrent hospital admissions. The authors aimed to find out whether the use of an angiotensin ...
February 9, 2011 (London, United Kingdom) — Substituting a generic angiotensin-receptor blocker (ARB), losartan, for the more expensive, branded ARB candesartan (Amias, Takeda) could save the UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback